Trademark: 97710260
Word
MARCH THERAPEUTICS
Status Date
Tuesday, July 30, 2024
Filing Date
Thursday, December 8, 2022
Published for Opposition
Tuesday, December 5, 2023
5 Pharmaceutical preparations for mitochondrial and nuclear genome engineering, DNA writing, molecular recording, synthetic gene circuit design, and protein and viral engineering for the treatment of disease
44 medical treatment using mitochondrial and nuclear genome engineering, DNA writing, molecular recording, synthetic gene circuit design, and protein and viral engineering for the treatment of disease
42 biotechnological research in the field of mitochondrial and nuclear genome engineering, DNA writing, molecular recording, synthetic gene circuit design, and protein and viral engineering
Jan 6, 2023
New Application Office Supplied Data Entered
Sep 13, 2023
Assigned To Examiner
Sep 15, 2023
Non-Final Action Written
Sep 15, 2023
Non-Final Action E-Mailed
Sep 15, 2023
Notification Of Non-Final Action E-Mailed
Oct 30, 2023
Teas Response To Office Action Received
Oct 30, 2023
Correspondence Received In Law Office
Oct 31, 2023
Teas/Email Correspondence Entered
Nov 1, 2023
Examiners Amendment -Written
Nov 1, 2023
Notification Of Examiners Amendment E-Mailed
Nov 1, 2023
Examiners Amendment E-Mailed
Nov 1, 2023
Examiner's Amendment Entered
Nov 1, 2023
Approved For Pub - Principal Register
Dec 5, 2023
Published For Opposition
Nov 15, 2023
Notification Of Notice Of Publication E-Mailed
Jan 30, 2024
Noa E-Mailed - Sou Required From Applicant
Jul 30, 2024
Sou Teas Extension Received
Jul 30, 2024
Notice Of Approval Of Extension Request E-Mailed
Jul 30, 2024
Sou Extension 1 Granted
Jul 30, 2024
Sou Extension 1 Filed
Dec 5, 2023
Official Gazette Publication Confirmation E-Mailed
Trademark Alertz updated from USPTO on 2030-01-24
